Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Guangdong Kanghua Healthcare Co., Ltd. Class H ( (HK:3689) ).
Guangdong Kanghua Healthcare Group Co., Ltd. reported its interim results for the six months ending June 30, 2025, showing a slight revenue decrease of 0.3% to RMB981.5 million compared to the same period in 2024. Despite the revenue dip, the company turned around its financial performance with a profit of RMB32.6 million, a significant improvement from a loss of RMB24.7 million in the previous year. The adjusted EBITDA saw a notable increase of 38.7% to RMB126.7 million, reflecting improved operational efficiency. However, the Board decided not to recommend an interim dividend for this period.
The most recent analyst rating on (HK:3689) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Guangdong Kanghua Healthcare Co., Ltd. Class H stock, see the HK:3689 Stock Forecast page.
More about Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the healthcare industry. The company is involved in providing healthcare services, with a focus on delivering medical and healthcare solutions to its clients.
Average Trading Volume: 38,535
Technical Sentiment Signal: Hold
Current Market Cap: HK$665.4M
See more data about 3689 stock on TipRanks’ Stock Analysis page.